Indonesia · Delayed Price · Currency is IDR PT Merck Tbk Statistics
Total Valuation
PT Merck Tbk has a market cap or net worth of IDR 1.62 trillion. The enterprise value is 1.17 trillion.
| Market Cap | 1.62T |
| Enterprise Value | 1.17T |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Jun 8, 2026 |
Share Statistics
PT Merck Tbk has 448.00 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 448.00M |
| Shares Outstanding | 448.00M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.17% |
| Float | 59.81M |
Valuation Ratios
The trailing PE ratio is 6.78.
| PE Ratio | 6.78 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 1.71 |
| P/FCF Ratio | 3.26 |
| P/OCF Ratio | 3.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.24, with an EV/FCF ratio of 2.35.
| EV / Earnings | 4.90 |
| EV / Sales | 0.85 |
| EV / EBITDA | 3.24 |
| EV / EBIT | 3.56 |
| EV / FCF | 2.35 |
Financial Position
The company has a current ratio of 5.34, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.34 |
| Quick Ratio | 3.50 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.03 |
| Interest Coverage | 143.23 |
Financial Efficiency
Return on equity (ROE) is 26.76% and return on invested capital (ROIC) is 39.01%.
| Return on Equity (ROE) | 26.76% |
| Return on Assets (ROA) | 18.62% |
| Return on Invested Capital (ROIC) | 39.01% |
| Return on Capital Employed (ROCE) | 32.46% |
| Weighted Average Cost of Capital (WACC) | 5.36% |
| Revenue Per Employee | 3.84B |
| Profits Per Employee | 666.25M |
| Employee Count | 358 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 2.29 |
Taxes
In the past 12 months, PT Merck Tbk has paid 108.93 billion in taxes.
| Income Tax | 108.93B |
| Effective Tax Rate | 31.35% |
Stock Price Statistics
The stock price has increased by +25.78% in the last 52 weeks. The beta is 0.19, so PT Merck Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +25.78% |
| 50-Day Moving Average | 3,784.00 |
| 200-Day Moving Average | 3,634.10 |
| Relative Strength Index (RSI) | 43.65 |
| Average Volume (20 Days) | 15,595 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Merck Tbk had revenue of IDR 1.38 trillion and earned 238.52 billion in profits. Earnings per share was 532.43.
| Revenue | 1.38T |
| Gross Profit | 585.26B |
| Operating Income | 327.84B |
| Pretax Income | 347.45B |
| Net Income | 238.52B |
| EBITDA | 353.73B |
| EBIT | 327.84B |
| Earnings Per Share (EPS) | 532.43 |
Balance Sheet
The company has 465.12 billion in cash and 15.96 billion in debt, with a net cash position of 449.17 billion or 1,002.61 per share.
| Cash & Cash Equivalents | 465.12B |
| Total Debt | 15.96B |
| Net Cash | 449.17B |
| Net Cash Per Share | 1,002.61 |
| Equity (Book Value) | 949.23B |
| Book Value Per Share | 2,121.98 |
| Working Capital | 879.39B |
Cash Flow
In the last 12 months, operating cash flow was 519.09 billion and capital expenditures -22.39 billion, giving a free cash flow of 496.70 billion.
| Operating Cash Flow | 519.09B |
| Capital Expenditures | -22.39B |
| Depreciation & Amortization | 25.89B |
| Net Borrowing | -6.29B |
| Free Cash Flow | 496.70B |
| FCF Per Share | 1,108.71 |
Margins
Gross margin is 42.54%, with operating and profit margins of 23.83% and 17.34%.
| Gross Margin | 42.54% |
| Operating Margin | 23.83% |
| Pretax Margin | 25.26% |
| Profit Margin | 17.34% |
| EBITDA Margin | 25.71% |
| EBIT Margin | 23.83% |
| FCF Margin | 36.11% |
Dividends & Yields
This stock pays an annual dividend of 275.00, which amounts to a dividend yield of 7.62%.
| Dividend Per Share | 275.00 |
| Dividend Yield | 7.62% |
| Dividend Growth (YoY) | 61.76% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 51.44% |
| FCF Payout Ratio | 41.04% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 7.59% |
| Earnings Yield | 14.75% |
| FCF Yield | 30.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.
| Last Split Date | Dec 21, 2015 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |